Search
for
Sort by
Research 30 of 403
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- The Triumph of JAK Inhibitors for the Treatment of Alopecia Areata
- Alopecias in humans: biology, pathomechanisms and emerging therapies
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Treatment of frontal fibrosing alopecia: literature review 2020-2025
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Advances in Topical Therapies for Clinically Relevant and Prevalent Forms of Alopecia
- Alopecia Areata: An Updated Review for 2023
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
- Alopecia Areata of the Nails: Diagnosis and Management
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Poster Presentations
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Dermatologic Adverse Events from Cancer Treatments
- Upadacitinib: A New Weapon for the Treatment of Twenty-Nail Dystrophy
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Review of Promising Off-Label Use of Deucravacitinib
- Hair Loss in an 11-year-old
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Minoxidil: a comprehensive review
- Periungual lesions secondary to chemotherapy with docetaxel